[Chevychelov]

Digoxin is mainly given to an elderly and frailer subset of
patients with AF and is thus associated with an increased
mortality When these and other differences in patient characteristics
are accounted for, digoxin use appears to be neutral for
the long-term mortality and major cardiovascular events in
patients with AF.
[Ссылки доступны только зарегистрированным пользователям ]